medigraphic.com
SPANISH

MediSan

ISSN 1029-3019 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 04

<< Back Next >>

MediSan 2012; 16 (04)

Presumptive diagnosis of the macroglobulinemia of Waldenström

Izquierdo CAD
Full text How to cite this article

Language: Spanish
References: 10
Page: 618-621
PDF size: 127.27 Kb.


Key words:

man, macroglobulinemia of Waldenström, primary monoclonal gammapathy, pancytopenia, proteinemia.

ABSTRACT

The case report of a 60 year-old patient is described who was assisted in his health area for presenting apparently banal symptoms and mucocutaneous pallor. The hemochemical tests and the hematimetry revealed severe pancytopenia and marked proteinemia, reason why other complementary tests were carried out, to check the presence of primary monoclonal gammapathy or associated with some neoplasic process. Primary macroglobulinemia was found, so the existence of the disease of Waldenström was confirmed.


REFERENCES

  1. Romaní F, Cuadra J, Atencia F, Canelo C. Macroglobulinemia de Waldenström. Presentación de un caso. An Fac Méd. 2008;69 (2): 112-6.

  2. Moró I, Oliver C, Stevenazzi M, Guillermo C, Pierri S, Decaro J. Enfermedad de Von Willebrand adquirida en un linfoma linfoplasmocitario/macroglobulinemia de Waldenström: reporte de caso. Rev Med Urug. 2010; 26 (4):246-52.

  3. Moragrega J. Macroglobulinemia primaria o de Waldenström. [citado 12 Sep 2011]. Disponible en: http://www.revistabioanalisis.com/arxius/notas/Nota6_13.pdf

  4. Vijay A, Gertz MA. Macroglobulinemia de Waldenström. Blood. 2007; 109(2): 5096-103.

  5. Fonseca R., Hayman S. Waldenström macroglobulinemia. Br J Haematol. 2007; 138(6):700-20.

  6. Burwick N, Roccaro AM, Leleu X, Ghobrial IM. Targeted therapies in Waldenström macroglobulinemia. Curr Opin Invetig Drugs. 2008; 9(6):631-7.

  7. Dimopoulos MA, Chen C, Kastritis E, Gavriatopoulou M, Treon SP. Bortezomib as a treatment option in patients with Waldenström macroglobulinemia. Clin Lymph Myel Leuk. 2010; 10(2):110-7.

  8. Dimopoulos MA, Gertz MA, Gastritis E, García Sanz R, Kimby EK, Leblond V, et al. Update on treatments recommendations from the Fourt International Workshop on Waldenstrom´s Macroglobulinemia. J Clin Oncol. 2009; 27(1):120-6.

  9. Adam Z, Pour L, Krejcí M, Koristek Z, Navrátil M, Krivanová, et al. Treatment Waldenström macroglobulinemia. The experience of one centre. Vnitr Lek. 2009, 55(1):9-17.

  10. Gertz MA. Waldenström macroglobulinemia: 2011 update on diagnosis, risk stratification and management. Am J Hematol. 2011; 86 (5):411-6.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

MediSan. 2012;16